HK Stock MarketDetailed Quotes

06978 IMMUNOTECH-B

Watchlist
  • 1.820
  • -0.080-4.21%
Market Closed Nov 7 16:08 CST
936.54MMarket Cap-2765P/E (TTM)

IMMUNOTECH-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Operating income
Operating expenses
Gross profit
Administrative expenses
7.94%-23.05M
45.53%-53.22M
45.87%-25.04M
6.28%-97.71M
-9.73%-46.25M
-51.92%-104.25M
-54.71%-42.15M
-147.21%-68.63M
-122.42%-27.25M
-137.96%-27.76M
Research and development expenses
-22.61%-91.12M
-0.63%-177.33M
25.73%-74.32M
26.76%-176.22M
6.77%-100.06M
13.64%-240.61M
-13.02%-107.32M
-349.58%-278.63M
-306.07%-94.96M
-98.82%-61.98M
Revaluation surplus
----
----
----
----
----
----
----
-544.03%-16.98M
-4,929.79%-19.42M
--3.83M
-Changes in the fair value of other assets
----
----
----
----
----
----
----
-544.03%-16.98M
-4,929.79%-19.42M
--3.83M
Special items of operating profit
271.11%25.46M
-134.98%-96.41M
-306.38%-14.88M
-575.60%-41.03M
113.76%7.21M
91.62%-6.07M
110.77%3.37M
-244.05%-72.51M
-132.54%-31.33M
-331.96%-21.07M
Operating profit
22.35%-88.71M
-3.81%-326.96M
17.88%-114.23M
10.25%-314.96M
4.79%-139.1M
19.65%-350.94M
15.52%-146.1M
-308.23%-436.74M
-249.44%-172.95M
-216.96%-106.98M
Financing cost
11.92%-3.85M
-38.86%-8.52M
-41.12%-4.37M
-66.80%-6.14M
-106.12%-3.1M
-53.96%-3.68M
-34.56%-1.5M
-15.41%-2.39M
-7.51%-1.12M
-82.38%-2.07M
Earning before tax
21.96%-92.56M
-4.48%-335.48M
16.59%-118.6M
9.45%-321.1M
3.66%-142.2M
19.25%-354.62M
15.20%-147.6M
-302.67%-439.13M
-244.46%-174.07M
-212.58%-109.05M
After-tax profit from continuing operations
21.96%-92.56M
-4.48%-335.48M
16.59%-118.6M
9.45%-321.1M
3.66%-142.2M
19.25%-354.62M
15.20%-147.6M
-302.67%-439.13M
-244.46%-174.07M
-212.58%-109.05M
Earning after tax
21.96%-92.56M
-4.48%-335.48M
16.59%-118.6M
9.45%-321.1M
3.66%-142.2M
19.25%-354.62M
15.20%-147.6M
-302.67%-439.13M
-244.46%-174.07M
-212.58%-109.05M
Minority profit
91.60%-41K
77.90%-660K
73.90%-488K
-663.68%-2.99M
-507.14%-1.87M
-376.83%-391K
-541.67%-308K
67.59%-82K
45.45%-48K
-107.38%-253K
Profit attributable to shareholders
21.67%-92.52M
-5.25%-334.82M
15.83%-118.11M
10.20%-318.11M
4.73%-140.33M
19.32%-354.22M
15.36%-147.3M
-303.53%-439.05M
-244.97%-174.02M
-212.95%-108.8M
Basic earnings per share
21.74%-0.18
-4.84%-0.65
14.81%-0.23
10.14%-0.62
6.90%-0.27
30.30%-0.69
36.96%-0.29
-241.38%-0.99
-253.85%-0.46
-163.64%-0.29
Diluted earnings per share
21.74%-0.18
-4.84%-0.65
14.81%-0.23
10.14%-0.62
6.90%-0.27
30.30%-0.69
36.96%-0.29
-241.38%-0.99
-253.85%-0.46
-0.29
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Operating income
Operating expenses
Gross profit
Administrative expenses 7.94%-23.05M45.53%-53.22M45.87%-25.04M6.28%-97.71M-9.73%-46.25M-51.92%-104.25M-54.71%-42.15M-147.21%-68.63M-122.42%-27.25M-137.96%-27.76M
Research and development expenses -22.61%-91.12M-0.63%-177.33M25.73%-74.32M26.76%-176.22M6.77%-100.06M13.64%-240.61M-13.02%-107.32M-349.58%-278.63M-306.07%-94.96M-98.82%-61.98M
Revaluation surplus -----------------------------544.03%-16.98M-4,929.79%-19.42M--3.83M
-Changes in the fair value of other assets -----------------------------544.03%-16.98M-4,929.79%-19.42M--3.83M
Special items of operating profit 271.11%25.46M-134.98%-96.41M-306.38%-14.88M-575.60%-41.03M113.76%7.21M91.62%-6.07M110.77%3.37M-244.05%-72.51M-132.54%-31.33M-331.96%-21.07M
Operating profit 22.35%-88.71M-3.81%-326.96M17.88%-114.23M10.25%-314.96M4.79%-139.1M19.65%-350.94M15.52%-146.1M-308.23%-436.74M-249.44%-172.95M-216.96%-106.98M
Financing cost 11.92%-3.85M-38.86%-8.52M-41.12%-4.37M-66.80%-6.14M-106.12%-3.1M-53.96%-3.68M-34.56%-1.5M-15.41%-2.39M-7.51%-1.12M-82.38%-2.07M
Earning before tax 21.96%-92.56M-4.48%-335.48M16.59%-118.6M9.45%-321.1M3.66%-142.2M19.25%-354.62M15.20%-147.6M-302.67%-439.13M-244.46%-174.07M-212.58%-109.05M
After-tax profit from continuing operations 21.96%-92.56M-4.48%-335.48M16.59%-118.6M9.45%-321.1M3.66%-142.2M19.25%-354.62M15.20%-147.6M-302.67%-439.13M-244.46%-174.07M-212.58%-109.05M
Earning after tax 21.96%-92.56M-4.48%-335.48M16.59%-118.6M9.45%-321.1M3.66%-142.2M19.25%-354.62M15.20%-147.6M-302.67%-439.13M-244.46%-174.07M-212.58%-109.05M
Minority profit 91.60%-41K77.90%-660K73.90%-488K-663.68%-2.99M-507.14%-1.87M-376.83%-391K-541.67%-308K67.59%-82K45.45%-48K-107.38%-253K
Profit attributable to shareholders 21.67%-92.52M-5.25%-334.82M15.83%-118.11M10.20%-318.11M4.73%-140.33M19.32%-354.22M15.36%-147.3M-303.53%-439.05M-244.97%-174.02M-212.95%-108.8M
Basic earnings per share 21.74%-0.18-4.84%-0.6514.81%-0.2310.14%-0.626.90%-0.2730.30%-0.6936.96%-0.29-241.38%-0.99-253.85%-0.46-163.64%-0.29
Diluted earnings per share 21.74%-0.18-4.84%-0.6514.81%-0.2310.14%-0.626.90%-0.2730.30%-0.6936.96%-0.29-241.38%-0.99-253.85%-0.46-0.29
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data